use of Amritadi tablet in management of side effects of radiotherapy in oral cancer
Phase 2
Completed
- Conditions
- Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
- Registration Number
- CTRI/2023/03/050379
- Lead Sponsor
- Government akhand Anand ayurveda college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Patient diagnosed with oral squamous cell carcinoma
Patient sign and symptoms of oral suamous cell carcinoma
Post surgical
Post chemotherapy
TNM criteria T1-13 N1-N3 M0
Exclusion Criteria
Age below 18 or above 60 year
Metastasis
Uncontrolled DM or HTN Hiv HbsAg cardiac and renal diseases
Total Trismus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method primary outcome will assess on based of subjective and objective criteria like pain in oral cavity dysphagia irregular bowel habit anorexia odynophegia flatulence Trismus oral mucositis weight <br/ ><br>And patient will get relief in side effects of radiotherapyTimepoint: 30 days
- Secondary Outcome Measures
Name Time Method Quality of life of cancer patients will be improvedTimepoint: 30 days